La Jolla, Calif., April 4, 2018 – Evan Y. Snyder, M.D., Ph.D., professor and founding director, Center for Stem Cells & Regenerative Medicine at Sanford Burnham Prebys Medical Discovery Institute (SBP) and professor at the University of California San Diego, has been elected to membership in the Association of American Physicians (AAP). AAP is a prestigious national society of physician-scientists who are elected based on their important scientific contributions that have ultimately impacted human health. Snyder will be inducted at the AAP annual meeting on April 21, 2018 in Chicago, Illinois.
“Evan is highly deserving of this honor,” says Kristiina Vuori, M.D., Ph.D., president of SBP. “His pioneering research on the properties of stem cells has led to applications in a broad range of neurologic conditions, many in clinical trials today.”
Snyder studies the basic and translational biology of stem cells (particularly neural) with the goal of understanding normal and aberrant development, tissue homeostasis and plasticity, inter-cellular communication, oncogenesis, and recovery of function. His lab uses stem cells to model disease pathogenesis and pathophysiology (for pathway mapping, therapeutic target identification, and drug discovery). He is a practicing clinician, a leader in regional ethics programs, and engaged in graduate and medical school education. He served two terms as Chairman of the FDA’s Cellular, Tissue, and Gene Therapy Advisory Committee.
Snyder earned his M.D. and Ph.D. (in neuroscience) from the University of Pennsylvania and received training in Philosophy, Psychology, and Linguistics at Oxford University. He began his career as a physician-scientist at Harvard Medical School and Boston Children’s Hospital where, in addition to running a lab and multidisciplinary research program, he remained clinically active in pediatrics, pediatric neurology, and newborn intensive care. In 2003, after 23 years at Harvard, he was recruited to SBP.
Sanford Burnham Prebys Medical Discovery Institute (SBP) is an independent nonprofit medical research organization that conducts world-class, collaborative, biological research and translates its discoveries for the benefit of patients. SBP focuses its research on cancer, immunity, neurodegeneration, metabolic disorders and rare children’s diseases. The Institute invests in talent, technology and partnerships to accelerate the translation of laboratory discoveries that will have the greatest impact on patients. Recognized for its world-class NCI-designated Cancer Center and the Conrad Prebys Center for Chemical Genomics, SBP employs about 1,000 scientists and staff in San Diego (La Jolla), Calif., and Orlando (Lake Nona), Fla. For more information, visit us at SBPdiscovery.org or on Facebook at facebook.com/SBPdiscovery and on Twitter @SBPdiscovery.
MEDIA CONTACTRegister for reporter access to contact details
AAP annual meeting, April 21, 2018